Physician profile
Daniel Plotnick
NPI 1356486039
$13,647.65
in general payments reported to CMS, 2019-2025
42 companies · $1,971 in 2025
The $1,971 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,412 · 2020: $734 · 2021: $744 · 2022: $2,064 · 2023: $2,826 · 2024: $2,896 · 2025: $1,971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,693.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,405.86 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,216.16 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $993.05 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $970.45 | 2019-2025 | Jardiance |
| Medtronic, INC. | $905.21 | 2021-2025 | Onyx Frontier, Symplicity G3, Micra |
| Edwards Lifesciences Corporation | $784.46 | 2019-2025 | Sapien 3 Ultra Resilia |
| Amgen INC. | $771.00 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $754.75 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $698.02 | 2019-2025 | Farxiga, Wainua |
| Abbott Laboratories | $485.77 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Amarin Pharma, INC. | $485.63 | 2019-2023 | |
| Alnylam Pharmaceuticals INC. | $470.06 | 2022-2025 | Onpattro, Amvuttra |
| Sanofi-Aventis U.S. LLC | $404.89 | 2019-2024 | |
| Boston Scientific Corporation | $325.85 | 2022-2024 | Watchman Access System, Watchman, Resonate El Icd Vr |
| Esperion Therapeutics, INC. | $295.11 | 2020-2025 | Nexletol |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $282.58 | 2023-2025 | |
| Novo Nordisk INC | $278.10 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $272.50 | 2019-2023 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $201.27 | 2023-2025 | Opsumit, Uptravi |
| Abiomed | $139.38 | 2020-2024 | Impella |
| Merck Sharp & Dohme LLC | $135.82 | 2022-2024 | Verquvo |
| Preventice Services, LLC | $132.34 | 2019 | |
| Atricure, INC. | $130.16 | 2019-2023 | |
| Lexicon Pharmaceuticals, INC. | $117.68 | 2023-2024 | Inpefa |
| Irhythm Technologies, INC. | $116.01 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Kiniksa Pharmaceuticals, Ltd. | $115.89 | 2022-2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $97.21 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $96.54 | 2024 | Arcalyst |
| Philips North America LLC | $85.39 | 2022-2023 | |
| Gilead Sciences, INC. | $74.00 | 2019 | |
| Kestra Medical Technology Services, INC. | $63.24 | 2025 | Assure Wcd |
| Baxter Healthcare | $58.27 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Medicomp INC | $48.05 | 2024 | Telepatch Cardiac Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $35.83 | 2023-2024 | |
| Heartflow, INC. | $35.36 | 2025 | |
| Biotronik INC. | $30.22 | 2019-2021 | |
| Cardiva Medical, INC. | $29.38 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic Vascular, INC. | $27.73 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $27.57 | 2020-2021 | |
| Lantheus Medical Imaging, INC. | $19.99 | 2019 | |
| Itamar Medical INC | $18.62 | 2021 | |
| Braemar Manufacturing, LLC | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Plotnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.